FLS
78
-2
ADSK
72
-3
MUR
44
-4
NSC
62
-3
JWN
53
5
MAC
65
-9
NOC
50
-7
LOW
56
-3
EMN
52
-3
PPL
52
-2
GS
79
-4
CVX
32
-5
NUE
58
-6
HCP
76
-2
WAT
65
4
MO
62
5
MRK
23
-5
STZ
55
2
BAX
27
-2
AAP
39
-3
FLS
78
-2
ADSK
72
-3
MUR
44
-4
NSC
62
-3
JWN
53
5
MAC
65
-9
NOC
50
-7
LOW
56
-3
EMN
52
-3
PPL
52
-2
GS
79
-4
CVX
32
-5
NUE
58
-6
HCP
76
-2
WAT
65
4
MO
62
5
MRK
23
-5
STZ
55
2
BAX
27
-2
AAP
39
-3
Financhill
Back

Bio-Path Holdings Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Sell
15

BPTH
Bio-Path Holdings

Last Price:
0.87
Seasonality Move:
-10.83%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Bio-Path Holdings Price Quote

$0.87
-0.01 (-0.76%)
(Updated: November 13, 2024 at 5:55 PM ET)

Bio-Path Holdings Key Stats

Sell
15
Bio-Path Holdings (BPTH) is a Sell
Day range:
$0.86 - $0.90
52-week range:
$0.80 - $12.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.73%
Volume:
29.6K
Avg. volume:
2.4M
1-year change:
-92.81%
Market cap:
$2.2M
Revenue:
$0
EPS:
$-16.67

How Much Does Bio-Path Holdings Make?

Data Unavailable

Is Bio-Path Holdings Growing As A Company?

Data Unavailable

Bio-Path Holdings Stock Price Performance

  • Did Bio-Path Holdings Stock Go Up Last Month?
    Bio-Path Holdings share price went down by -22.41% last month
  • Did BPTH's Share Price Rise Over The Last Year?
    BPTH share price fell by -92.81% over the past 1 year

What Is Bio-Path Holdings 52-Week High & Low?

Bio-Path Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bio-Path Holdings?

  • How Much Debt Does Bio-Path Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bio-Path Holdings Have?
    Cash and short term investments quarterly total is $4M
  • What Is Bio-Path Holdings’s Book Value Per Share?
    Book value per share is 0.57

Is Bio-Path Holdings Cash Flow Positive?

  • What Is BPTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.9M
  • What Is Bio-Path Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.4M
  • What Is Bio-Path Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bio-Path Holdings Return On Invested Capital

Data Unavailable

Bio-Path Holdings Earnings Date & Stock Price

Bio-Path Holdings Competitors

  • Who Are Bio-Path Holdings's Competitors?
    Below is a list of companies who compete with Bio-Path Holdings or are related in some way:
    • Aadi Bioscience Inc (AADI)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Bio-Path Holdings Dividend Yield

Bio-Path Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 24.68%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.00
Upside from Last Price: 2181.28%

Major Shareholders

  • How many BPTH shares are owned by institutional investors?
    212.6K BPTH shares are owned by institutional investors
  • How many BPTH shares are owned by insiders?
    0 BPTH shares are owned by insiders